Sofia Parrasia, Ildikò Szabò, Mario Zoratti & Lucia Biasutto. (2022) Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges. Molecular Pharmaceutics 19:11, pages 3700-3729.
Crossref
Farah Rehan, Md. Emranul Karim, Nafees Ahemad, Mohd. Farooq Shaikh, Manish Gupta, Siew Hua Gan & Ezharul Hoque Chowdhury. (2022) A comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubicin in a xenograft model of breast tumor. Journal of Pharmaceutical Investigation 52:6, pages 787-804.
Crossref
Yu Wang, Feng Jia & Yong Lin. (2022) Poly(butyl cyanoacrylate) nanoparticles-delivered β-nerve growth factor promotes the neurite outgrowth and reduces the mortality in the rat after traumatic brain injury. Nanotechnology 33:13, pages 135101.
Crossref
Amin Mehrabian, Mohammad Mashreghi, Saba Dadpour, Ali Badiee, Leila Arabi, Seyedeh Hoda Alavizadeh, Seyedeh Alia Moosavian & Mahmoud Reza Jaafari. (2022) Nanocarriers Call the Last Shot in the Treatment of Brain Cancers. Technology in Cancer Research & Treatment 21, pages 153303382210809.
Crossref
Tayo Alex Adekiya, Pierre P.D. Kondiah, Pradeep Kumar & Yahya E. Choonara. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors
695
729
.
Yamir Islam, Andrew G. Leach, Jayden Smith, Stefano Pluchino, Christopher R. Coxon, Muttuswamy Sivakumaran, James Downing, Amos A. Fatokun, Meritxell Teixidò & Touraj Ehtezazi. (2021) Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles. Advanced Science 8:11.
Crossref
Debora Santonocito, Giuseppina Raciti, Agata Campisi, Giovanni Sposito, Annamaria Panico, Edy Siciliano, Maria Sarpietro, Elisabetta Damiani & Carmelo Puglia. (2021) Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization. Nanomaterials 11:2, pages 391.
Crossref
Qing You & BernhardA Sabel. (2021) Nanoparticles as a tool to deliver drugs to the retina and brain: an update. Neural Regeneration Research 16:2, pages 283.
Crossref
Kristian Kempe & Joseph A. Nicolazzo. 2021. Nanomedicines for Brain Drug Delivery. Nanomedicines for Brain Drug Delivery
1
27
.
Majid Hassanzadeganroudsari, Majid Soltani, Amir Heydarinasab, Vasso Apostolopoulos, Azim Akbarzadehkhiyavi & Kulmira Nurgali. (2020) Targeted nano-drug delivery system for glioblastoma therapy: In vitro and in vivo study. Journal of Drug Delivery Science and Technology 60, pages 102039.
Crossref
Vikas Pandey, Tanweer Haider, Ashok R. Chandak, Avik Chakraborty, Sharmila Banerjee & Vandana Soni. (2020) Surface modified silk fibroin nanoparticles for improved delivery of doxorubicin: Development, characterization, in-vitro studies. International Journal of Biological Macromolecules 164, pages 2018-2027.
Crossref
Qing You, Maxim Sokolov, Lisa Grigartzik, Werner Hintz, Berend G. M. van Wachem, Petra Henrich-Noack & Bernhard A. Sabel. (2019) How Nanoparticle Physicochemical Parameters Affect Drug Delivery to Cells in the Retina via Systemic Interactions. Molecular Pharmaceutics 16:12, pages 5068-5075.
Crossref
A. I. Skorobogatova, O. A. Terent’eva, V. A. Vainshtein, S. V. Okovityi, E. V. Flisyuk & I. A. Narkevich. (2019) Targeted Transport as a Promising Method of Drug Delivery to the Central Nervous System (Review). Pharmaceutical Chemistry Journal 53:9, pages 845-851.
Crossref
Majid Saeedi, Masoumeh Eslamifar, Khadijeh Khezri & Solmaz Maleki Dizaj. (2019) Applications of nanotechnology in drug delivery to the central nervous system. Biomedicine & Pharmacotherapy 111, pages 666-675.
Crossref
Georgi Yordanov. 2019. Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics. Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics
59
79
.
Elisabetta Esposito, Markus Drechsler, Paolo Mariani, Federica Carducci, Michela Servadio, Francesca Melancia, Patrizia Ratano, Patrizia Campolongo, Viviana Trezza, Rita Cortesi & Claudio Nastruzzi. (2017) Lipid nanoparticles for administration of poorly water soluble neuroactive drugs. Biomedical Microdevices 19:3.
Crossref
Elisabetta Esposito, Rita Cortesi, Markus Drechsler, Jie Fan, Bingmei M. Fu, Laura Calderan, Silvia Mannucci, Federico Boschi & Claudio Nastruzzi. (2017) Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro / in vivo behavior. European Journal of Pharmaceutics and Biopharmaceutics 115, pages 285-296.
Crossref
Tilman Schuster, Astrid Mühlstein, Claudia Yaghootfam, Olga Maksimenko, Elena Shipulo, Svetlana Gelperina, Jörg Kreuter, Volkmar Gieselmann & Ulrich Matzner. (2017) Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A. Journal of Controlled Release 253, pages 1-10.
Crossref
Bastian Raudszus, Katrin Partikel, Dennis Mulac & Klaus Langer. (2017) Characterisation and cellular uptake of polysorbate 80-coated PLA nanoparticles. Materials Today: Proceedings 4, pages S193-S199.
Crossref
Y. Liu & Q. He. 2017. Neurotoxicity of Nanomaterials and Nanomedicine. Neurotoxicity of Nanomaterials and Nanomedicine
33
57
.
Robert A. Yokel. (2016) Physicochemical properties of engineered nanomaterials that influence their nervous system distribution and effects. Nanomedicine: Nanotechnology, Biology and Medicine 12:7, pages 2081-2093.
Crossref
John Kealy & Matthew Campbell. 2016. Resistance to Targeted Therapies Against Adult Brain Cancers. Resistance to Targeted Therapies Against Adult Brain Cancers
69
87
.
David J. Mc Carthy, Meenakshi Malhotra, Aoife M. O’Mahony, John F. Cryan & Caitriona M. O’Driscoll. (2014) Nanoparticles and the Blood-Brain Barrier: Advancing from In-Vitro Models Towards Therapeutic Significance. Pharmaceutical Research 32:4, pages 1161-1185.
Crossref
Elisabetta Esposito, Laura Ravani, Markus Drechsler, Paolo Mariani, Catia Contado, Janne Ruokolainen, Patrizia Ratano, Patrizia Campolongo, Viviana Trezza, Claudio Nastruzzi & Rita Cortesi. (2015) Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study. Materials Science and Engineering: C 48, pages 328-336.
Crossref
Xiao-xia Song, Hong-ping Wan, Jin-sheng Zhang & Qun Tang. (2014) Paclitaxel-loaded KMnF3 nanoparticles for cancer imaging and therapy in vivo. Journal of Nanoparticle Research 16:11.
Crossref
Nadine Voigt, Petra Henrich-Noack, Sarah Kockentiedt, Werner Hintz, Jürgen Tomas & Bernhard A. Sabel. (2014) Surfactants, not size or zeta-potential influence blood–brain barrier passage of polymeric nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 87:1, pages 19-29.
Crossref
Jörg Kreuter. (2014) Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?. Advanced Drug Delivery Reviews 71, pages 2-14.
Crossref
Robert A. Yokel, Jason M. Unrine, Peng Wu, Binghui Wang & Eric A. Grulke. (2014) Nanoceria biodistribution and retention in the rat after its intravenous administration are not greatly influenced by dosing schedule, dose, or particle shape. Environ. Sci.: Nano 1:6, pages 549-560.
Crossref
Antonietta Vilella, Giovanni Tosi, Andreas M. Grabrucker, Barbara Ruozi, Daniela Belletti, Maria Angela Vandelli, Tobias M. Boeckers, Flavio Forni & Michele Zoli. (2014) Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution. Journal of Controlled Release 174, pages 195-201.
Crossref
Therese S. Salameh & William A. Banks. 2014. Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders. Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders
277
299
.
Babak Kateb & John HeissJoseph Cheatle & Michele Aizenberg. 2013. The Textbook of Nanoneuroscience and Nanoneurosurgery. The Textbook of Nanoneuroscience and Nanoneurosurgery
381
394
.
G Tosi, B Ruozi, L Badiali, L Bondioli, D Belletti, F Forni & M Vandelli. 2012. Nanotechnology in Health Care. Nanotechnology in Health Care
107
168
.
Stefanie Wohlfart, Svetlana Gelperina & Jörg Kreuter. (2012) Transport of drugs across the blood–brain barrier by nanoparticles. Journal of Controlled Release 161:2, pages 264-273.
Crossref
Hauke Kloust, Elmar Pöselt, Sascha Kappen, Christian Schmidtke, Andreas Kornowski, Werner Pauer, Hans-Ulrich Moritz & Horst Weller. (2012) Ultrasmall Biocompatible Nanocomposites: A New Approach Using Seeded Emulsion Polymerization for the Encapsulation of Nanocrystals. Langmuir 28:18, pages 7276-7281.
Crossref
Freha Hansali, Man Wu, Dalila Bendedouch & Emmanuelle Marie. (2012) n-Butyl cyanoacrylate miniemulsion polymerization via the phase inversion composition method. Colloids and Surfaces A: Physicochemical and Engineering Aspects 393, pages 133-138.
Crossref
Juan M. Irache, Irene Esparza, Carlos Gamazo, Maite Agüeros & Socorro Espuelas. (2011) Nanomedicine: Novel approaches in human and veterinary therapeutics. Veterinary Parasitology 180:1-2, pages 47-71.
Crossref
Stefanie Wohlfart, Alexander S. Khalansky, Svetlana Gelperina, David Begley & Jörg Kreuter. (2011) Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier. Journal of Controlled Release 154:1, pages 103-107.
Crossref
Santiago Rojas, Juan D. Gispert, Roberto Martín, Sergio Abad, Cristina Menchón, Deborah Pareto, Víctor M. Víctor, Mercedes Álvaro, Hermenegildo García & J. Raúl Herance. (2011)
Biodistribution of Amino-Functionalized Diamond Nanoparticles.
In Vivo
Studies Based on
18
F Radionuclide Emission
. ACS Nano 5:7, pages 5552-5559.
Crossref
Pengcheng Zhang, Luojuan Hu, Yucai Wang, Jun Wang, Linyin Feng & Yaping Li. (2010) Poly(ε-caprolactone)-Block-poly(ethyl Ethylene Phosphate) Micelles for Brain-Targeting Drug Delivery: In Vitro and In Vivo Valuation. Pharmaceutical Research 27:12, pages 2657-2669.
Crossref
Angela R. Jones & Eric V. Shusta. 2009. Therapeutic Monoclonal Antibodies. Therapeutic Monoclonal Antibodies
483
502
.
Karine Andrieux & Patrick Couvreur. (2009) Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 1:5, pages 463-474.
Crossref
Man Wu, Céline Frochot, Edith Dellacherie & Emmanuelle Marie. (2009) Well‐Defined Poly(butyl cyanoacrylate) Nanoparticles via Miniemulsion Polymerization. Macromolecular Symposia 281:1, pages 39-46.
Crossref
M. Wu, E. Dellacherie, A. Durand & E. Marie. (2009) Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization. 2. PEG-based surfactants. Colloids and Surfaces B: Biointerfaces 69:1, pages 147-151.
Crossref
N. Debotton, O. Giladi, M. Parnes & S. Benita. (2009) Novel high-content paclitaxel palmitate nanospheres for improved cancer treatment. Journal of Drug Delivery Science and Technology 19:4, pages 275-282.
Crossref
Luca Costantino, Giovanni Tosi, Barbara Ruozi, Lucia Bondioli, Maria Angela Vandelli & Flavio Forni. 2009. Nanoneuroscience and Nanoneuropharmacology. Nanoneuroscience and Nanoneuropharmacology
35
69
.
Jörg Kreuter & Svetlana Gelperina. (2018) Use of Nanoparticles for Cerebral Cancer. Tumori Journal 94:2, pages 271-277.
Crossref
G. Tosi, L. Costantino, F. Rivasi, B. Ruozi, E. Leo, A.V. Vergoni, R. Tacchi, A. Bertolini, M.A. Vandelli & F. Forni. (2007) Targeting the central nervous system: In vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. Journal of Controlled Release 122:1, pages 1-9.
Crossref
Angela R. Jones & Eric V. Shusta. (2007) Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation. Pharmaceutical Research 24:9, pages 1759-1771.
Crossref
S. Charlton, N.S. Jones, S.S. Davis & L. Illum. (2007) Distribution and clearance of bioadhesive formulations from the olfactory region in man: Effect of polymer type and nasal delivery device. European Journal of Pharmaceutical Sciences 30:3-4, pages 295-302.
Crossref
Wei Lu, Jin Wan, Qing Zhang, Zhenjue She & Xinguo Jiang. (2007) Aclarubicin-loaded cationic albumin-conjugated pegylated nanoparticle for glioma chemotherapy in rats. International Journal of Cancer 120:2, pages 420-431.
Crossref
B. Petri, A. Bootz, A. Khalansky, T. Hekmatara, R. Müller, R. Uhl, J. Kreuter & S. Gelperina. (2007) Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: Revisiting the role of surfactants. Journal of Controlled Release 117:1, pages 51-58.
Crossref
Hari Shanker Sharma & Aruna Sharma. 2007. Neurobiology of Hyperthermia. Neurobiology of Hyperthermia
245
273
.